Recruiting studies: Allergic Rhinoconjunctivitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
Phase 3 · 32 location(s) · Inmunotek S.L. · NCT04891237 Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure chamber-a Randomi
Phase 4 · 1 location(s) · Wroclaw Medical University · NCT06778213 Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
Phase 3 · 27 location(s) · Inmunotek S.L. · NCT04898283 Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study
NA · 6 location(s) · University of Melbourne · NCT07055542 Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
Phase 3 · 32 location(s) · Inmunotek S.L. · NCT04435990 Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df
Phase 3 · 19 location(s) · Inmunotek S.L. · NCT07348302

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.